The mutational status of p53 can influence its recognition by human T-cells
Sign Up to like & getrecommendations! Published in 2017 at "OncoImmunology"
DOI: 10.1080/2162402x.2017.1285990
Abstract: ABSTRACT p53 was reported to be an attractive immunotherapy target because it is mutated in approximately half of human cancers, resulting in its inactivation and often accumulation in tumor cells. Peptides derived from p53 are… read more here.
Keywords: mutational status; status p53; recognition; influence ... See more keywords